Successful treatment of relapsed <i>KMT2A</i> rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report

Jialiang Xu, Yangpeng Chen, Yan Zhang, Fuhua Zhang, Yu Zhang, Jing Sun, Na Xu

Open source

DOI
10.1177/20406207261484015
Published
2026-08
Container
Therapeutic Advances in Hematology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406207261484015,
  title = {Successful treatment of relapsed
                    <i>KMT2A</i>
                    rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report},
  author = {Jialiang Xu and Yangpeng Chen and Yan Zhang and Fuhua Zhang and Yu Zhang and Jing Sun and Na Xu},
  year = {2026},
  journal = {Therapeutic Advances in Hematology},
  doi = {10.1177/20406207261484015},
  url = {https://doi.org/10.1177/20406207261484015}
}

RIS

TY  - JOUR
TI  - Successful treatment of relapsed
                    <i>KMT2A</i>
                    rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report
AU  - Jialiang Xu
AU  - Yangpeng Chen
AU  - Yan Zhang
AU  - Fuhua Zhang
AU  - Yu Zhang
AU  - Jing Sun
AU  - Na Xu
PY  - 2026
JO  - Therapeutic Advances in Hematology
DO  - 10.1177/20406207261484015
UR  - https://doi.org/10.1177/20406207261484015
ER  - 

APA

Xu, J., Chen, Y., Zhang, Y., Zhang, F., Zhang, Y., Sun, J., & Xu, N. (2026). Successful treatment of relapsed <i>KMT2A</i> rearranged AML with central nervous system involvement using revumenib in combination with venetoclax and azacitidine: A case report. Therapeutic Advances in Hematology. https://doi.org/10.1177/20406207261484015

Source records